EssilorLuxottica: 2021 Universal Registration Document filed
2021 Universal Registration Document filed Charenton-le-Pont, France, (March 25, 2022 – 6:30 pm) – EssilorLuxottica announces the availability of its...
Month: March 2022
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order
Company Sets New Quarterly Record for Number of Individual E-Commerce Order Transactions New York, NY, March 25, 2022 (GLOBE NEWSWIRE)...
TransCode Therapeutics Interview to Air on Bloomberg U.S. on the RedChip Money Report®
BOSTON, March 25, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a biopharmaceutical company committed to defeating cancer using RNA...
Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA
TWYNEO will be officially launched for commercial availability in Spring 2022.NESS ZIONA, Israel, March 25, 2022 (GLOBE NEWSWIRE) -- Sol-Gel Technologies,...
Correction: Active Biotech Year End Report 2021
The correction refers to the administrative costs for the period January – December 2021 that due to oversight have been...
Dr Michael Turner Announces New Blog Post: How to Prevent & Treat Covid19
How To Prevent And Treat Covid-19 Dr. Michael Turner Los Angeles, March 25, 2022 (GLOBE NEWSWIRE) -- Dr. Michael Turner...
Extendicare women leading the way to improve seniors’ care
Globe and Mail Report on Business names Extendicare to annual Women Lead Here listMARKHAM, Ontario, March 25, 2022 (GLOBE NEWSWIRE)...
InvestmentPitch Media Video Discusses Reliq Health’s Signing of an Agreement with a US Contract Research Organization and Expansion into Clinical Trials Market
VANCOUVER, British Columbia, March 25, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global...
Inspirational Child with MLD, Calliope Joy, Passes Away
Calliope Joy Carr defied all odds by living with rare genetic disease for 12 yearsBALA CYNWYD, Pa., March 25, 2022 (GLOBE...
Biocure Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - March 25, 2022) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) ("Biocure" or the "Company")...
Advent Galaxy(TM), Division of TGI and AllStarHealth Brands Retain GIANT.NET to Explore Creation of its Own Crypto and Development of NFTs
MIAMI, FL / ACCESSWIRE / March 25, 2022 / TGI SOLAR POWER GROUP INC. ("TGI"), a diversified technology and environmentally...
Franchise Global Health Inc. Announces Completion Of Qualifying Transaction
NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRESTORONTO, ON and VANCOUVER, BC / ACCESSWIRE / March 25, 2022...
Dr. June Gower Explains What It Took to Become a Field Medic in the Air Force and U.S. Army
Former field medic Dr. June Gower explains what it takes to fulfill this role in the armed forces.HOOD RIVER, OR...
Aquarius Surgical Technologies Announces Share Issuance
TORONTO, ON / ACCESSWIRE / March 25, 2022 / Aquarius Surgical Technologies Inc. (CSE:ASTI) announces that it has issued 100,000...
Xcelerate, Inc. Files Medical Surgical Device Patent
MAULDIN, SC / ACCESSWIRE / March 25, 2022 / Xcelerate, Inc. (OTC Markets:XCRT) recently announced that it signed a Membership...
NLS Pharmaceutics to Participate in Maxim Group 2022 Virtual Growth Conference
ZURICH, SWITZERLAND / ACCESSWIRE / March 25, 2022 - NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss...
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., enters into a Non-Binding Term Sheet for a $5 Billion Committed Equity Financing Facility to be Effective in Connection with the Closing of the Merger with Vickers Vantage Corp I
PALO ALTO, Calif., March 25, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc....
INmune Bio, Inc. Spotlights Key Findings in Presentations at AD/PD™ 2022
International Conference on Alzheimer's and Parkinson's Diseases Provides New Insights into the Role of Neuroinflammation in AD and the Promise...
CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma
Polivy plus R-CHP showed first clinically meaningful improvement in PFS with comparable safety in people with previously untreated diffuse large...
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
Reported 27-patient dosimetry data from the lead-in cohort of the SPLASH trial Randomization phase of SPLASH trial ongoing, top line...